News
NEWS
-
newsSelected as a final nominee for the "Japan Venture Award".
-
newsCelaid will be speaking at the "JHVS2022 Global Business Pitch Session", sponsored by the MHLW
-
newsCelaid selected as a finalist in the "Japan Healthcare Business Contest (JHeC) 2023" organized by METI.
-
financingCelaid Therapeutics, developer of novel cell therapies, announces 500 million yen Series A financing.
-
newsCelaid will be speaking at the "ACADEMIA ENTREPRENEUR SUMMIT" hosted by Forbes
-
news
Celaid will participate in the semi-finals of the "Japan Healthcare Business Contest (JHeC)" organized by METI.
-
newsSelected to participate in JETRO's Acceleration program "SCAP"
-
newsCelaid will exhibit at "BioJapan 2022"
-
newsCelaid will participate in Nagoya City's pitch event "NAGOYA CONNÉCT".